1997
DOI: 10.1016/s0306-3623(97)00018-9
|View full text |Cite
|
Sign up to set email alerts
|

Effects of a lipoxygenase inhibitor on digoxin-induced cardiac arrhythmias in the isolated perfused guinea-pig heart

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1998
1998
2005
2005

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…In this study, it is unknown whether the enhanced production of leukotrienes in the cardiac tissues mediates digoxin-induced tachyarrhythmias. It has recently been shown in our previous study that BW A4C, a 5-lipoxygenase inhibitor, did not prevent the genesis of VT and VF inspite of the fact that it suppressed the digoxin-induced elevation LTB 4 levels in the coronary effluent [8]. Therefore, we postulated that excess LTB 4 synthesis could not be involved in the digoxin-induced arrhythmias and the impairment of cardiac functions; whereas pretreatment with a dual inhibitor of cyclooxygenase and lipoxygenase, BW 755C (5 and 10 mgWkg -1 i.v.…”
Section: Discussionmentioning
confidence: 75%
See 1 more Smart Citation
“…In this study, it is unknown whether the enhanced production of leukotrienes in the cardiac tissues mediates digoxin-induced tachyarrhythmias. It has recently been shown in our previous study that BW A4C, a 5-lipoxygenase inhibitor, did not prevent the genesis of VT and VF inspite of the fact that it suppressed the digoxin-induced elevation LTB 4 levels in the coronary effluent [8]. Therefore, we postulated that excess LTB 4 synthesis could not be involved in the digoxin-induced arrhythmias and the impairment of cardiac functions; whereas pretreatment with a dual inhibitor of cyclooxygenase and lipoxygenase, BW 755C (5 and 10 mgWkg -1 i.v.…”
Section: Discussionmentioning
confidence: 75%
“…Treatment with leukotriene receptor antagonists and dual inhibitors (lipoxygenase and cyclooxygenase inhibitors) of arachidonic acid has been shown to attenuate the occurrence of digoxin-induced arrhythmias and prevent digoxin-induced ventricular fibrillation (VF) with a significant delay in mortality in anesthetized guinea pigs [6,7]. However, in a previous study done by us in a guinea-pig isolated heart preparation, it was reported that the lipoxygenase inhibitor, BW A4C, lacked any protective action on digoxin-induced arrhythmias, although it effectively inhibited the digoxininduced increase in LTB 4 in the coronary effluent [8].…”
Section: Introductionmentioning
confidence: 99%